SEC 13F Intelligence

Cove Street Capital, LLC / ANIK

Cove Street Capital, LLC’s Anika Therapeutics Inc Position

Does Cove Street Capital, LLC own Anika Therapeutics Inc (ANIK)? Yes — 102.0K shares worth $958,386 (+1.25% of its 13F portfolio) as of Q3 2025, up from 74.1K shares the prior filed quarter.

Position Value
$958,386
Q3 2025
Shares
102.0K
% of Portfolio
+1.25%
Quarters Held
4
currently held

Position History ANIK

Reported value by quarter
Q1 ’20: $578,000Q1 ’20Q1 ’25: $1MQ1 ’25Q2 ’25: $783,967Q2 ’25Q3 ’25: $958,386Q3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025102.0K$958,386+1.25%
Q2 202574.1K$783,967+1.15%
Q1 202574.9K$1M+1.77%
Q1 202020.0K$578,000+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cove Street Capital, LLC’s full portfolio or all institutional holders of ANIK.